BioEclosion SL has developed a patented IVD device that enhances the current state of rapid diagnostics. The test integrates a single-use cartridge –specific for each application– and a portable, robust, user-friendly, battery-operated reader that adheres to the REASSURED guidelines defined by the WHO. Our core technology is based on magnetic immunoassays with electrochemical quantification. It provides a universal solution as IVD diagnostic tools by harnessing the potential of magnetic particles, encompassing applications for i) communicable diseases and emerging infectious diseases, non-communicable diseases (for instance cancer, cardiovascular and diabetes biomarkers), and ii) targets affecting water and food supplies.